$29.31
-0.11-0.37%
At Close: -
$29.33
0.020.07%
After Hours: 7:59 PM EDT
15 minutes delayed
Pfizer reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pfizer using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-30 | $0.60 | $0.46 | 30.4 % |
Mar 2024 | 2024-05-01 | $0.82 | $0.52 | 57.7 % |
Dec 2023 | 2024-01-30 | $0.10 | $-0.22 | 145.4 % |
Sep 2023 | 2023-10-31 | $-0.17 | $-0.32 | 46.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-30 | $13.28B | $13.02B | 2.02 % |
Mar 2024 | 2024-05-01 | $14.88B | $14.01B | 6.20 % |
Dec 2023 | 2024-01-30 | $14.25B | $14.21B | 0.27 % |
Sep 2023 | 2023-10-31 | $13.23B | $12.72B | 4.03 % |
Pfizer (PFE) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on July 30, 2024 for Q2.
The Actual EPS was $0.60, which beat the estimate of $0.46.
The Actual Revenue was $13.3B, which beat the estimate of $13B.
Browse earnings estimates, EPS, and revenue on all stocks.